Abstract
Antifibrinolytic therapy is important in hemostatic control during modern paediatric cardiac and non-cardiac surgery. There continues to be controversy regarding the available agents, e(epsilon)-aminocaproic acid and TXA, to utilize; whether there is a clearly superior choice. This discussion highlights the pharmacology differences between e(epsilon)-aminocaproic acid and TXA and reviews the data comparing the two drugs in paediatric cardiac surgical patients.
| Original language | English (US) |
|---|---|
| Title of host publication | You're Wrong, I'm Right |
| Subtitle of host publication | Dueling Authors Reexamine Classic Teachings in Anesthesia |
| Publisher | Springer International Publishing |
| Pages | 85-86 |
| Number of pages | 2 |
| ISBN (Electronic) | 9783319431697 |
| ISBN (Print) | 9783319431673 |
| DOIs | |
| State | Published - Jan 1 2016 |
Keywords
- ?(epsilon)-aminocaproic acid
- Antifibrinolytics
- Neonatal anesthesia
- Pediatric anesthesia
- Pediatric cardiac anesthesia
- Seizures
- Tranexamic acid (TXA)
ASJC Scopus subject areas
- General Medicine